|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1995-3-13
|
|
pubmed:abstractText |
We performed a phase I study of a novel system of complete hepatic venous isolation and extracorporeal chemofiltration in patients with unresectable hepatocellular carcinoma (HCC) to determine (a) whether systemic exposure to doxorubicin could be limited after high-dose hepatic arterial infusion (HAI), and (b) the hepatic maximum tolerated dose (MTD) of doxorubicin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1068-9265
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
389-99
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:7850540-Adult,
pubmed-meshheading:7850540-Aged,
pubmed-meshheading:7850540-Balloon Dilation,
pubmed-meshheading:7850540-Carcinoma, Hepatocellular,
pubmed-meshheading:7850540-Chemotherapy, Cancer, Regional Perfusion,
pubmed-meshheading:7850540-Combined Modality Therapy,
pubmed-meshheading:7850540-Dose-Response Relationship, Drug,
pubmed-meshheading:7850540-Doxorubicin,
pubmed-meshheading:7850540-Female,
pubmed-meshheading:7850540-Hemodynamics,
pubmed-meshheading:7850540-Hemofiltration,
pubmed-meshheading:7850540-Hepatic Veins,
pubmed-meshheading:7850540-Humans,
pubmed-meshheading:7850540-Infusions, Intra-Arterial,
pubmed-meshheading:7850540-Liver Circulation,
pubmed-meshheading:7850540-Liver Neoplasms,
pubmed-meshheading:7850540-Male,
pubmed-meshheading:7850540-Middle Aged,
pubmed-meshheading:7850540-Postoperative Complications,
pubmed-meshheading:7850540-Time Factors,
pubmed-meshheading:7850540-Vena Cava Filters
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Complete hepatic venous isolation and extracorporeal chemofiltration as treatment for human hepatocellular carcinoma: a phase I study.
|
|
pubmed:affiliation |
Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Clinical Trial, Phase I
|
